Heat shock protein pathway (HSP pathway)

The heat shock protein pathway, comprising a family of highly conserved heat shock proteins (HSPs) such as Hsp60, Hsp70, and Hsp90, plays a critical role in maintaining cellular proteostasis under both normal and stressful conditions. These molecular chaperones assist newly synthesized polypeptides to fold correctly, refold damaged or misfolded proteins, prevent unwanted aggregation, and facilitate transport across membranes within cells. The expression of these proteins is upregulated during various stresses including heat, oxidative damage, UV light exposure, infection, wound healing, and tissue remodeling. Heat shock proteins are central components of the cellular stress response system known as the heat-shock response, regulated primarily at the transcriptional level by heat shock factors like HSF1. Beyond their classical role in protein quality control, they participate actively in regulating apoptosis pathways and immune signaling. Some viruses exploit certain members of this family to enhance their replication cycles. Clinically significant roles have been identified for these pathways particularly in cancer where they stabilize multiple oncogenic client proteins; thus inhibitors targeting mainly Hsp90, but also other members like Hsp70, are being developed as anticancer agents. Additionally, their involvement extends into neurodegenerative disorders characterized by abnormal protein aggregation. Despite promising therapeutic potential through modulation of this pathway—especially via small molecule inhibitors—challenges remain due to their fundamental role across all cells which raises safety concerns related to toxicity when inhibited systemically. In summary, the heat shock protein pathway represents an essential biological system involved broadly in cell survival under stress with emerging importance as a therapeutic target across multiple diseases[1][2][3][4][5].

Other names

Heat shock proteinsHSP familymolecular chaperonesstress proteins

Drugs targeting heat shock proteins generally act by: - Inhibiting ATPase activity essential for chaperone function - Disrupting client protein stabilization leading to degradation of misfolded or oncogenic client proteins - Modulating the heat shock response transcriptional regulation via heat shock factor 1